Activated T cell therapy targeting glioblastoma cancer stem cells

Ken Miyaguchi(Cedars-Sinai Medical Center), John S. Yu(Cedars-Sinai Medical Center)

Scientific Reports

January 5, 2023

10.1038/s41598-022-27184-w

Cited by 8

Related Papers

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

|Molecular Cancer|2006|1.8k

Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma

|Cancer Research|2004|532

Modeling Patient-Derived Glioblastoma with Cerebral Organoids

|Cell Reports|2019|482

Hedgehog Signaling Regulates Brain Tumor-Initiating Cell Proliferation and Portends Shorter Survival for Patients with PTEN-Coexpressing Glioblastomas

|Stem Cells|2008|113

A Peroxisome Proliferator-activated Receptor-γ Agonist, Troglitazone, Facilitates Caspase-8 and -9 Activities by Increasing the Enzymatic Activity of Protein-tyrosine Phosphatase-1B on Human Glioma Cells

|Journal of Biological Chemistry|2005|67